The levonorgestrel intrauterine system: long-term contraception and therapeutic effects

Regine Sitruk-Ware; Pirjo Inki

doi:10.2217/17455057.1.2.171

The levonorgestrel intrauterine system: long-term contraception and therapeutic effects

Womens Health (Lond). 2005 Sep;1(2):171-82. doi: 10.2217/17455057.1.2.171.

Authors

Regine Sitruk-Ware¹, Pirjo Inki

Affiliation

¹ Population Council, 1230 York Avenue, New York 10021, USA. rsitrukware@popcbr.rockefeller.edu.

PMID: 19803834
DOI: 10.2217/17455057.1.2.171

Abstract

The levonorgestrel intrauterine system (Mirena((R))) has been developed as a long-acting method of contraception. This medicated device, inserted into the uterus, delivers a small daily dose of a progestin, levonorgestrel, into the uterine cavity. It is one of the most effective methods of contraception and is approved in more than 100 countries for 5 years of use.